India's fight against Covid-19 depends a lot on these 5 companies

ET Bureau|
​India Inc plays key tech role
1/6

​India Inc plays key tech role

As India gears to up to deal with increasing number of Covid-19 cases, a lot of its success will depend on the ability to start testing more people and provide the infrastructure necessary to deal with the critically ill.

While so far, the country has relied on imported testing kits, the Central Drugs Standard Control Organisations (CDSCO) on Monday granted approval to an Pune headquartered.

Getty Images
​Mylab Discovery Solutions
2/6

​Mylab Discovery Solutions

Mylab Discovery Solutions, which specialises in molecular diagnostic kits to start manufacturing testing kits. “On technical expertise we are absolutely at par with international standards if not better. We have the capability to manufacture four-five lakh tests a day once all the other companies get approvals,” said Veena Kohli, president, Association of Diagnostics Manufacturers of India.

The first Indian firm to be granted approval to start manufacturing testing kits, this company claims it can provide results in a few hours instead of the two-three days it currently takes.

(Representative Image)

Getty Images
​Skanray
3/6

​Skanray

The Mysuru based firm makes low-cost ventilators is working at ramping up capacity and working with vthe Niti Aayog, the Defence Research and Development Organisation (DRDO) and other state bodies on the design and supply of locally sourced components.

(Representative Image)

Getty Images
​Trivitron
4/6

​Trivitron

Headquartered in Chennai, the medical devices company is currently waiting for the ICMR and CDSCO to approve its testing kit and says that it can provide test results within a few hours.

(Representative Image)

Getty Images
​Molbio
5/6

​Molbio

The company says that it has received approval for its testing kit from the Drug Controller General of India, which takes it a step closer to launching these kits once it is validated by the National Institute of Virology.

(Representative Image)

Getty Images
​CoSara Diagnotics
6/6

​CoSara Diagnotics

This joint venture between Symbiotics and US’s CoDiagnostics said that it had received CDSCO approval for its testing kits, and would go ahead with manufacturing once the NIV validation comes in. The research and tech on molecular diagnostics will be shared by the US partner and the manufacturing would happen in India.

(Representative Image)

Getty Images

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

X
User